11. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study. (1st January 2021) Authors: Morimoto, Kenji; Uchino, Junji; Yokoi, Takashi; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Hibino, Makoto; Takeda, Takayuki; Yamaguchi, Hiroyuki; Takumi, Chieko; Takeshita, Masafumi; Chihara, Yusuke; Yamada, Takahiro; Hiranuma, Osamu; Morimoto, Yoshie; Iwasaku, Masahiro; Kaneko, Yoshiko; Yama... Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Inhibition of c-Jun N-terminal kinase signaling increased apoptosis and prevented the emergence of ALK-TKI-tolerant cells in ALK-rearranged non-small cell lung cancer. (1st December 2021) Authors: Tanimura, Keiko; Yamada, Tadaaki; Horinaka, Mano; Katayama, Yuki; Fukui, Sarina; Morimoto, Kenji; Nakano, Takayuki; Tokuda, Shinsaku; Morimoto, Yoshie; Iwasaku, Masahiro; Kaneko, Yoshiko; Uchino, Junji; Yoneda, Kazue; Yano, Seiji; Sakai, Toshiyuki; Takayama, Koichi Journal: Cancer letters Issue: Volume 522(2021) Page Start: 119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer. Issue 4 (30th December 2020) Authors: He, Yayi; Song, Lele; Wang, Hao; Chen, Peixin; Liu, Yu; Sun, Hui; Li, Xiaobin; Dang, Shiying; Liu, Guifeng; Liu, Xinyi; Chen, Shifu; Zhang, Xiaoni; Hofman, Paul; Uchino, Junji; Park, Henry S.; Pacheco, Jose M.; Tabbò, Fabrizio; Xu, Mingyan; Dai, Jiawei; He, Kan Journal: Advanced science Issue: Volume 8:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial. (16th January 2019) Authors: Nakao, Akira; Hiranuma, Osamu; Uchino, Junji; Sakaguchi, Chikara; Kita, Toshiyuki; Hiraoka, Noriya; Ishizuka, Tamotsu; Kubota, Yutaka; Kawasaki, Masayuki; Goto, Yasuhiro; Imai, Hisao; Hattori, Noboru; Nakatomi, Keita; Uramoto, Hidetaka; Uryu, Kiyoaki; Fukuda, Minoru; Uchida, Yasuki; Yokoyama, Tos... Journal: Oncologist Issue: Volume 24:Number 5(2019) Page Start: 593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer. (30th April 2019) Authors: Chihara, Yusuke; Yoshimura, Akihiro; Date, Koji; Takemura, Yoshizumi; Tamiya, Nobuyo; Kohno, Yoshihito; Imabayashi, Tatsuya; Takeuchi, Mayumi; Kaneko, Yoshiko; Yamada, Tadaaki; Ueda, Mikio; Arimoto, Taichiro; Uchino, Junji; Iwasaki, Yoshinobu; Takayama, Koichi Journal: Oncologist Issue: Volume 24:Number 8(2019) Page Start: 1033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer. (21st October 2019) Authors: Takayama, Koichi; Ichiki, Masao; Matsumoto, Takemasa; Ebi, Noriyuki; Akamine, Shinji; Tokunaga, Shoji; Yamada, Tadaaki; Uchino, Junji; Nakanishi, Yoichi Journal: Oncologist Issue: Volume 25:Number 3(2020) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis. Issue 3 (23rd January 2019) Authors: Yoshimura, Akihiro; Yamada, Tadaaki; Tsuji, Taisuke; Hamashima, Ryosuke; Shiotsu, Shinsuke; Yuba, Tatsuya; Takumi, Chieko; Uchino, Junji; Hiraoka, Noriya; Takayama, Koichi Journal: Thoracic cancer Issue: Volume 10:Issue 3(2019) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801. (18th May 2020) Authors: Takayama, Koichi; Takeshita, Masafumi; Inoue, Koji; Ichiki, Masao; Fujita, Masaki; Harada, Taishi; Shiraishi, Yoshimasa; Wataya, Hiroshi; Tokunaga, Shoji; Yamada, Tadaaki; Uchino, Junji; Sugio, Kenji Journal: Oncologist Issue: Volume 25:Number 8(2020) Page Start: e1146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer. (22nd July 2019) Authors: Takayama, Koichi; Ichiki, Masao; Tokunaga, Shoji; Inoue, Koji; Kawasaki, Masayuki; Uchino, Junji; Nakanishi, Yoichi Journal: Oncologist Issue: Volume 24:Number 11(2019) Page Start: 1420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study). (May 2020) Authors: Yamada, Tadaaki; Uchino, Junji; Chihara, Yusuke; Shimamoto, Takayuki; Iwasaku, Masahiro; Tamiya, Nobuyo; Kaneko, Yoshiko; Kiyomi, Fumiaki; Takayama, Koichi Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗